# Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients

> **NCT01495169** · PHASE1 · COMPLETED · sponsor: **Vanda Pharmaceuticals** · enrollment: 33 (actual)

## Conditions studied

- Safety and Tolerability of Iloperidone

## Interventions

- **DRUG:** iloperidone (oral tablet)

## Key facts

- **NCT ID:** NCT01495169
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01495169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01495169, "Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01495169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*